| Name | Title | Contact Details |
|---|
Nexus Communications is a North Wales, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MEDO USA, Inc. is a Hanover Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of care they deliver to patients.
We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.
Xeridiem is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.